20-44424132-AGCT-AGCTGCT
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 12P and 1B. PM1PM2PP5_Very_StrongBP3
The NM_175914.5(HNF4A):c.956_958dupTGC(p.Leu319dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,196 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★★).
Frequency
Consequence
NM_175914.5 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- maturity-onset diabetes of the young type 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- monogenic diabetesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- diabetes mellitus, noninsulin-dependentInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Fanconi renotubular syndrome 4 with maturity-onset diabetes of the youngInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, G2P
- hyperinsulinism due to HNF4A deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- maturity-onset diabetes of the youngInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HNF4A | NM_175914.5 | c.956_958dupTGC | p.Leu319dup | disruptive_inframe_insertion | Exon 8 of 10 | ENST00000316673.9 | NP_787110.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| HNF4A | ENST00000316673.9 | c.956_958dupTGC | p.Leu319dup | disruptive_inframe_insertion | Exon 8 of 10 | 1 | NM_175914.5 | ENSP00000315180.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461196Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726910 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
The HNF4A c.956_958dup; p.Leu319dup variant (rs776489992) is reported in the literature in individuals affected with MODY (Pearson 2005, Yorifuji 2023). This variant is also reported in ClinVar (Variation ID: 435439). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. This variant duplicates a single leucine residue leaving the rest of the protein in-frame. However, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. References: Pearson ER et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia. 2005 May;48(5):878-85. PMID: 15830177. Yorifuji T et al. Targeted gene panel analysis of Japanese patients with maturity-onset diabetes of the young-like diabetes mellitus: Roles of inactivating variants in the ABCC8 and insulin resistance genes. J Diabetes Investig. 2023 Mar;14(3):387-403. PMID: 36504295. -
- -
Type 2 diabetes mellitus;C1852093:Maturity-onset diabetes of the young type 1;C4014962:Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young Pathogenic:1
- -
Hyperinsulinism due to HNF4A deficiency Pathogenic:1
- -
Monogenic diabetes Pathogenic:1
The c.956_958dup variant in the hepatocyte-nuclear factor 4-alpha gene, HNF4A, is a 3 base pair insertion resulting in the in-frame addition of 1 amino acid at codon 319 (p.(Leu_319_Pro320insLeu)) within exon 8 of NM_175914.5. This variant is located within the ligand-binding domain (codons 180-220 and 300-350) of HNF4A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in 8 unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PS4; PMID: 15830177, internal lab contributors). One of these individuals had a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, family member with diazoxide-responsive neonatal hyperinsulinism) (PP4; internal lab contributors). This variant segregated with diabetes, with 6 informative meioses in 4 families (PP1_Strong; PMID: 15830177, internal lab contributors). While the c.956_958dup variant is predicted to change the length of the protein due to an in-frame insertion of a single amino acid, it is in a repeat region where the reference sequence contains a tract of 5 leucines and there is a relatively common 4 leucine variant (c.956_958del p.Leu319del, Popmax filtering allele frequency = 0.00011), and PM4 was not applied. In summary, c.956_958dup meets the criteria to be classified as Pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.0.0, approved 10/11/2023): PP1_Strong, PS4, PP4, PM1_Supporting, PM2_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at